Steen CB, Luca BA, Esfahani MS, Azizi A, Sworder BJ, Nabet BY, Kurtz DM, Liu CL, Khameneh F, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles AJ, Newman AM, Alizadeh AA(2021) The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma Cancer Cell, 39(10), 1422-1437.e10 DOI 10.1016/j.ccell.2021.08.011, PubMed 34597589
Sanjiv K, Calderón-Montaño JM, Pham TM, Erkers T, Tsuber V, Almlöf I, Höglund A, Heshmati Y, Seashore-Ludlow B, Nagesh Danda A, Gad H, Wiita E, Göktürk C, Rasti A, Friedrich S, Centio A, Estruch M, Våtsveen TK, Struyf N, Visnes T, Scobie M, Koolmeister T, Henriksson M, Wallner O, Sandvall Tet al.(2021) MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia Cancer Res, 81(22), 5733-5744 DOI 10.1158/0008-5472.CAN-21-0061, PubMed 34593524
Isaksen KT, Mastroianni MA, Rinde M, Rusten LS, Barzenje DA, Ramslien LF, Slaaen M, Jerm MB, Smeland EB, Rostoft S, Liestøl K, Brodtkorb M, Holte H(2021) A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL Blood Adv, 5(22), 4771-4782 DOI 10.1182/bloodadvances.2021004777, PubMed 34543384
Group leader: June H. Myklebust, Email: junehm@rr-research.no, Phone: +47 22781413 Postal address: Department of Cancer Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway